Tuesday, 3rd June Lancefield International Symposium for Streptococci and Streptococcal Diseases 2025

The Registration Desk will reopen for Poster Session 2: 5:00pm - 7:30pm

Invited Speaker: 

Prof Liesl Zuhlke - South African Medical Research Council, South Africa

• Rheumatic Heart Disease Interventions for Prevention in Africa: Current Status and Future Priorities - Liesl Zuhlke
• Phase I Trial of a Peptide-based Vaccine to Prevent Group A Streptococcal Infection - Michael F. Good
• Unravelling protective immunity against pharyngeal GAS challenge in non-human primates - Charles Armitage
• A randomised, double-blinded, placebo-controlled human challenge trial to establish the lowest penicillin concentration to prevent Streptococcus pyogenes pharyngitis (CHIPS). - Laurens Manning
• SToP (See, Treat, and Prevent) activities for skin disease control in remote Western Australia: a cluster randomised, stepped wedge Trial - Stephanie Enkel
• High dose, subcutaneous injections of benzathine penicillin G (SCIP) to prevent rheumatic fever: A single arm, phase IIa trial of safety and pharmacokinetics - Julie Bennett

Invited Speaker: 

Prof Kelly Doran - University of Colorado, United States

• Interkingdom interactions with Candida albicans promote Group B Streptococcal vaginal colonization - Kelly Doran
• Implementation and Impact of a Novel Rheumatic Heart Disease Screening Program in Uganda: Results from the ADUNU Program  - Scott Wirth
• Exploring mucosal humoral immunity to Streptococcus pyogenes in oral fluid within a longitudinal household cohort study in The Gambia. - Fatoumata Camara
• Salivary signatures: mapping the dynamic human proteome in Strep A pharyngitis - Anuk D Indraratna
• Incidence of invasive group A streptococcal infections and comparison of emm types from carriage, pharyngitis, and invasive infections in Indigenous communities in the Southwest United States - Catherine Sutcliffe
• Water access, sanitation and hygiene-related risk factors for Streptococcus pyogenes carriage and infection within households in The Gambia - Edwin P Armitage
• Evaluation of clinical decision rules for diagnosis of Streptococcus pyogenes pharyngitis in a tropical setting - John Hart

Lancefield Society Members are invited to attend the:

Members Meeting 

The Members Meeting will provide an update of the society's activities and will announce new Committee Members for The Lancefield Society. 

Please select one of three half-day tours during registration. 

• Distinct responses of conventional and unconventional T cells to Group A Streptococcus in healthy adults - Mohammad Ali
• Killing Strep A softly – towards standardised reagents for Streptococcus pyogenes immunoassays - Kristy I Azzopardi
•  Can Group B Streptococcus (GBS) strain diversity in carriage be recovered from low-abundance metagenomic samples? A simulation study - Ruchita Balasubramanian
• Global Population Biology and Tissue Tropism Correlates for M- and FCT-Region Genes - Debra E Bessen
• New insights into the regulatory networks that control streptococcal superantigen production - Stephan Brouwer
• PrsA in group A Streptococcus: implications for pathogenesis and therapeutic targeting - Yung-Chi Chang
• Regulatory mechanisms of GAC side chain modifications in Group A Streptococcus - Lorenzo G De la Parra Soto
• Glyburide as an adjunct agent to treat inflammatory changes associated with post-streptococcal cardiac pathology - Jasen Elford
• Multidrug resistance in group B streptococcus causing urinary tract infection exposes an erythromycin-driven protective effect against oxidative stress - Kelvin GK Goh
• Characterising cross-reactive properties of the antibody response to Group A Streptococcus (GAS) and in rheumatic heart disease - Zichen He
• How to utilize a genome-scale metabolic model and iModulon in the research of Streptococcus pyogenes M1 serotype - Yujiro Hirose
• Differences in glycan binding modulate M1 Streptococcus pyogenes tissue tropism - Kristin K Huse
• Search and characterization of novel RNA-binding proteins in Streptococcus pyogenes - Dmitriy Ignatov
• Transcriptomic predictors of delayed mortality in patients with invasive group A streptococcal disease - Ville Kailankangas
• Serologic responses in patients with invasive group A streptococcal disease and concomitant throat findings - Ville Kailankangas
• Population genomics of Streptococcus pyogenes in patients admitted at a tertiary hospital in Malawi (2012–2023) - Akuzike Kalizang'oma
• Pneumococcal-like capsule polysaccharide loci among Streptococcus mitis bloodstream isolates from infective endocarditis cases in the UK and Ireland from 2001-2016 - Akuzike Kalizang'oma
• Junk or adjunct? The place of protein synthesis inhibitors for treatment of severe invasive Streptococcus pyogenes infections in a time of rising clindamycin resistance - Louise Kelly
• Immune Responses In Siblings With Acute Rheumatic Fever – A Case Study - Natalie Lorenz
• Streptococcus pyogenes biofilm phenotypic and genotypic changes in response to host stressors - Georgia M McCorkell
• Novel Transporters Impacting the Pathophysiology of Group A Streptococcal Infections - Kevin S McIver
• Profiling inflammatory resolution over 6 months in acute rheumatic fever - Francis M Middleton
• Deciphering the pan-methylome of group A Streptococcus - August Mikucki
• The longitudinal characterisation of immune responses in the Rat Autoimmune Valvulitis model enables the assessment of disease severity and the identification of biomarkers for ARF/RHD screening - Rukshan Ahamed Mohamed Rafeek
• Role of streptococcal inhibitor of complement and streptococcal nephritogenic antigens in the pathogenesis of post-streptococcal glomerulonephritis - Mohammad Raguib Munif
• Group A Streptococcus modulates AMPK-mTOR signaling via NADase and inhibits p62-dependent oxidative stress response - Takashi Nozawa
• Close evolutionary relationship between recent serotype M1 group A streptococcus isolates in Scotland and Iceland - Randall J Olsen
• Differential immune responses in Group A Streptococcal Necrotizing Soft Tissue infections. - Laura Marcela Palma Medina
• Complement factor H and susceptibility to rheumatic heart disease - Tom Parks
• Exploring the structural basis for CovR dysregulation in Australian M1_UK Group A Streptococcus   - Jarrad Pritchard
• The impact of glucose on motility and colorectal cancer cell invasion in Streptococcus gallolyticus subspecies gallolyticus and related species - Adam Ralph
• Group A streptococcal infection outcomes: clues from salivary sialic acid and comparative genomic analyses - Chad Euler
• Detection of the hypervirulent chimeric emm4 lineage in Australia - Phoebe K Shaw
• Streptococcus pyogenes is readily aerosolised but survives poorly on plastic: a comparison of 8 pathogenic species - Christopher Smith
• Group A Streptococcus and its virulent phage: playing ‘hide and seek’ in the human host - Jenny M Steinmetz
• The stabilization of streptolysin S secreted from β-hemolytic streptococci in the presence of human serum albumin. - Atsushi Tabata
• Investigating tropism of group A Streptococcus to epithelial and endothelial cells - Vanessa Tenaglia
• Exploring the immunological properties of Group A Streptococcus pilus - Catherine Tsai
• Multidrug resistance in group B streptococcus causing urinary tract infection exposes an erythromycin-driven protective effect against oxidative stress - Glen Ulett
• The sil system of Streptococcus anginosus: A key factor for survival in mixed cultures - Verena Vogel
• Pharmacokinetics of intramuscular benzathine penicillin G: a meta-analysis investigating time spent above target concentrations   - Shakayla Walley
• Construction of isogenic M1_UK mutants lacking scarlet fever-associated exotoxins    - Jasmine Wells
• Respiratory Group A Strep infections in stem cell models reveals divergent airway and alveolar epithelial cell responses - Rhiannon Werder
• GAS regulation of zinc homeostasis during skin and soft tissue infection - Reid Wilkening
• Mechanism of host-inflammatory response against Streptolysin S produced by Streptococcus anginosus via intracellular Ca²⁺-influx - Yugo Yamamori
• ‘RHD in a dish’ -- Investigating the pathogenesis of Rheumatic Heart Disease using stem cell-derived heart valve organoids. - Serene Yeow
• Emerging role of biomarker-driven diagnostics in post-streptococcal glomerulonephritis - Tawakaltu Abdulrasheed-Adeleke
• A plasma protein biomarker signature that differentiates acute rheumatic fever from related clinical presentations - Tim Barnett
• The Immune Landscape of the Tonsils: A Critical Site for Understanding Group A Streptococcus Infections - Anna Bergonzini
• Systematic review and narrative synthesis of studies evaluating the characteristics of current Strep A molecular point-of-care tests towards implementation for Acute Rheumatic Fever (ARF) prevention. - Asha Bowen
• Analytical Evaluation of Three Commercially Available Molecular Point-of-Care Tests for Group A Streptococcus: A Harmonised Approach - Asha Bowen
• Improved detection of lymphocyte markers associated with rheumatic fever using engineered antibodies and multi-omics - Chad Euler
• Molecular diagnostics improve the detection of pathogenic streptococci causing complicated community-acquired pneumonia in children - Erin C Ho
• Investigating host-dependent antibiotic resistance in Streptococcus pyogenes - Bonnie L Hyatt
• Circulating prothymosin alpha and immunoglobulin G3 in acute rheumatic fever and rheumatic heart disease: A case control study - Tom Parks
• Antibody responses to conserved peptide sequences from the M-protein of group A streptococcus - David J McMillan
• Implementation of whole genome sequencing (WGS) replacing targeted emm gene sequencing in informing Group A Streptococcus pyogenes (GAS) outbreaks - Kartyk Moganeradj
• Development of a 10-plex electrochemiluminescent assay for quantifying specific serological immunoglobulin isotype and subclass responses to Streptococcus pyogenes antigens  - Michael Morici
• Identification of RNA Biomarkers for Acute Rheumatic Fever (ARF) - Lara Oberski
• Group A Streptococcus molecular point-of-care test performance in remote Australia - Janessa Pickering
• Detection of group B Streptococcus carriage among pregnant women by a cost-effective and faster approach based on MALDI-TOF MS - Tatiana Pinto
• Group A Streptococcus emm1/ST28: an emerging hipervirulent threat in Brazil - André Rio Tinto
• Development of a prototype for rapid point-of-care diagnosis of antibiotic-resistant Group A streptococcal and staphylococcal skin infections - Kalindu Rodrigo
• Diagnostic accuracy of the 2023 world heart federation screening criteria for rheumatic heart disease in a high-risk population - Joselyn Rwebembera
• Long-term persistence of Group A Streptococcal antibodies in a Rheumatic heart disease African cohort : A pilot study - Taariq Salie
• Comparative analysis of Strep A bacterial detection methods in an Australian paediatric urban pharyngitis surveillance study   - Anna Takahashi
• Possibility of developing a biomarker based rapid screening test for ARF/RHD - Brenda Vo
• Surveillance of Streptococus pyogenes induced pharyngitis in children from refugee and asylum seeker backgrounds via collaboration with a local health service - Ciara Baker
• Moorditj marp (strong skin): strengthening skin health outcomes through community driven research and translation initiatives - Asha Bowen
• Taking an environmental health approach to preventing Strep A infections and Acute Rheumatic Fever - Asha Bowen
• Significance of community engagement strategies for group a streptococcus surveillance. researchers’ experience from a pacific island context - Roneel RC Chandra
• Subcutaneous injections of penicillin: Convenient and effective treatment for Māori, Pacific Peoples and their whānau in preventing rheumatic heart disease - Julie Cooper
• Household transmission of Streptococcus pyogenes (Strep A): a review to inform potential environmental health interventions for remote living Aboriginal communities at high risk of rheumatic fever - Stephanie Enkel
• The human side of RHD: connecting personal stories to scientific solutions - Anu Gomanju
• Addressing rheumatic heart disease in the Pacific - Joseph H Kado
• Rapua te mea ngaro ka tau: culturally responsive governance applied to vaccine development - Shannon Leilua
• Identifying environmental risk factors for acute rheumatic fever (arf) - Ela Monteiro
• Cultural safety training for new zealand secondary prophylaxis providers for rheumatic fever - Monleigh MM Muliaumasealii
• Whitia kia ora indigenous health care model for rheumatic fever - Monleigh MM Muliaumasealii
• Determining the impact of acute rheumatic fever on children's quality of life - Emma Ndagire
• Parent Led Sample Collection: An Innovative Method for Enhancing Participant Recruitment in a Research Surveillance Study During a Pandemic - Elizabeth Negus
• Communication Strategies Used to Maximise Community-Based Participation in the Sore Throat Study in Perth and Melbourne - Elizabeth Negus
• The experience of streptococcal pharyngitis human challenge trial participants - Jane Oliver
• Gaining community insight into Group A streptococcus isolate research and care - Tira TPP Phillipson-puna
• The Wash Up – Understanding Specifications for Washing Clothes and Bedding to Reduce Skin Infections: An Integrated Approach - Kate Summer
• Transmission of Strep A via Fabric Fomites and the Role of Laundering: Knowns and Unknowns - Kate Summer
• Check4Strep a community-based pilot project to understand and respond to infection with Group A Streptococcus - Vicki Wade
• Infectious diseases associated with inadequate housing and Healthy Living Practice capacity in Australia: a systematic review - Rosemary Wyber
• Human antibodies to M-protein epitope-based vaccines demonstrate increase immunogenicity and Streptococcus pyogenes (StrepA) bactericidal activity - Christie T M Short
• Models of Vaccine Finance with an Application to Potential Group A Strep Vaccines - Daniel Tortorice
• Molecular dissection of Streptococcus suis surface glycans reveals conserved glycan motifs with implications in vaccine development - Nina M. van Sorge
• Delineating Humoral and Cellular Immune Responses Induced by a Peptide-Based Vaccine for Protection Against Streptococcus pyogenes - Despena Vedis
• Protective properties of Enn surface proteins against Group A Streptococcus. - Cyprien Widomski
• Streptococcus pyogenes evades antibody recognition through decoration of the Group A Lancefield antigen with glycerol phosphate - Astrid Hendriks
• Pericardial Effusion in Acute Rheumatic Fever and Rheumatic Heart Disease - Masood Sadiq